Blood sample collection
PD
Plasma samples for PK analysis of inclacumab were obtained before administration on day 1, at the end of infusion (EOI), and at approximately 2, 6, 12, 24, and 48 h after the EOI. Subsequent samples were collected at every study visit through week 29. Plasma, serum, and/or whole-blood samples for ADA, PD, and exploratory biomarkers were also collected before administration on day 1 and at selected subsequent visits through week 29.